BVT Knock-Out BIIB/ DE000VD4PT76 /
| 28/06/2024 08:19:40 | Chg.-0.08 | Bid09:11:11 | Ask09:11:11 | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 3.31EUR | -2.36% | 3.37 Bid Size: 8,000 |
3.54 Ask Size: 8,000 |
Biogen Inc | 195.22 USD | 31/12/2078 | Call |
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire
01:39
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
GlobeNewswire
01:10
Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease
GlobeNewswire
27/06
DEADLINE ALERT for BIIB, DRCT, FSLY, CRGE: Law Offices of Howard G. Smith Reminds Investors of Class...
GlobeNewswire
27/06
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 M...
GlobeNewswire
27/06
INmune Bio, Inc. Completes Blinded Interim Analysis of Phase II Alzheimer’s Disease Trial
GlobeNewswire
27/06
BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Sub...
GlobeNewswire
26/06
DEADLINE ALERT for CMBM, BIIB, DRCT, and FSLY: The Law Offices of Frank R. Cruz Reminds Investors of...
GlobeNewswire
25/06
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit with the Schall Law Fir...
GlobeNewswire
25/06
Biogen Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
GlobeNewswire
24/06
BIOGEN INC. (NASDAQ: BIIB) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Biogen Inc. Investors of U...
GlobeNewswire
24/06
TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®, Approved in the European Union
GlobeNewswire
24/06
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire
22/06
Securities Fraud Class Action Lawsuit Was Filed Against Biogen Inc. (BIIB) – Contact Kessler Topaz M...
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen...
GlobeNewswire
21/06
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Agains...
GlobeNewswire
20/06
DEADLINE ALERT for BIIB, DRCT, FSLY, CRGE: Law Offices of Howard G. Smith Reminds Investors of Class...
GlobeNewswire
20/06
BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Sub...
GlobeNewswire
20/06
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire
19/06
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit with the Schall Law Fir...
GlobeNewswire
18/06
Biogen Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before ...
GlobeNewswire
18/06
DEADLINE ALERT for CMBM, BIIB, DRCT, and FSLY: The Law Offices of Frank R. Cruz Reminds Investors of...
GlobeNewswire
17/06
BIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class ...
